The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer

S Koschel, DG Murphy, MS Hofman… - Current opinion in …, 2019 - journals.lww.com
Summary PSMA PET/CT is rapidly altering the landscape of primary staging in PCa. It
appears to be superior to conventional imaging for detecting regional and distant …

Detection and localisation of primary prostate cancer using 68gallium prostate‐specific membrane antigen positron emission tomography/computed tomography …

AA Kalapara, T Nzenza, HYC Pan, Z Ballok… - BJU …, 2020 - Wiley Online Library
Objective To compare the accuracy of 68gallium prostate‐specific membrane antigen
positron emission tomography/computed tomography (68Ga‐PSMA PET/CT) with …

Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy

TH Chan, A Haworth, A Wang, M Osanlouy, S Williams… - EJNMMI research, 2023 - Springer
Abstract Background Prostate-Specific Membrane Antigen (PSMA) PET/CT and
multiparametric MRI (mpMRI) are well-established modalities for identifying intra-prostatic …

Registration of presurgical MRI and histopathology images from radical prostatectomy via RAPSODI

M Rusu, W Shao, CA Kunder, JB Wang… - Medical …, 2020 - Wiley Online Library
Purpose Magnetic resonance imaging (MRI) has great potential to improve prostate cancer
diagnosis; however, subtle differences between cancer and confounding conditions render …

Progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer IMRT: An overview

EJ Her, A Haworth, P Rowshanfarzad, MA Ebert - Cancers, 2020 - mdpi.com
Advances in imaging have enabled the identification of prostate cancer foci with an initial
application to focal dose escalation, with subvolumes created with image intensity …

Biologically targeted radiation therapy: incorporating patient-specific hypoxia data derived from quantitative magnetic resonance imaging

EJ Her, A Haworth, Y Sun, S Williams, HM Reynolds… - Cancers, 2021 - mdpi.com
Simple Summary Recent clinical trials have demonstrated the capability of safely delivering
prostate radiotherapy with a simultaneous focal boost. These studies have also indicated …

[PDF][PDF] Detection and localisation of primary prostate cancer using 68Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens

AA Kalapara, T Nzenza, HY Pan, Z Ballok, S Ramdave… - BJU Int, 2019 - academia.edu
1 MR. ARVEEN ADITH KALAPARA (Orcid ID: 0000-0003-3003-2655) 2 DR. TATENDA
NZENZA (Orcid ID: 0000-0002-1157-7003) 3 PROF. MICHAEL S HOFMAN (Orcid ID: 0000 …

[HTML][HTML] Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after …

A Dutta, J Chan, A Haworth, DJ Dubowitz… - Physics and Imaging in …, 2024 - Elsevier
Background and purpose Radiomic features from MRI and PET are an emerging tool with
potential to improve prostate cancer outcomes. However, feature robustness due to image …

Histologic validation of auto-contoured dominant intraprostatic lesions on [18F] DCFPyL PSMA-PET imaging

R Alfano, GS Bauman, W Liu, JD Thiessen… - Radiotherapy and …, 2020 - Elsevier
Background PSMA-PET 1 has shown good concordance with histology, but there is a need
to investigate the ability of PSMA-PET to delineate DIL 2 boundaries for guided biopsy and …

[HTML][HTML] From Phantoms to Patients: Improved Fusion and Voxel-Wise Analysis of Diffusion-Weighted Imaging and FDG-Positron Emission Tomography in Positron …

K Deininger, P Korf, L Lauber, R Grimm, R Strecker… - Diagnostics, 2024 - mdpi.com
Hybrid positron emission tomography/magnetic resonance imaging (PET/MR) opens new
possibilities in multimodal multiparametric (m2p) image analyses. But even the …